Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels
1 other identifier
observational
158
1 country
2
Brief Summary
A prospective, multicenter post-market clinical follow-up study to evaluate the 10-year long-term safety and effectiveness of the Simplify Disc at two levels in subjects who were enrolled in the IDE study (NCT03123549) and/or post approval study (NCT04980378).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2023
CompletedStudy Start
First participant enrolled
January 18, 2023
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 10, 2029
December 22, 2025
December 1, 2025
6.1 years
January 11, 2023
December 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Composite Success Rate
Individual success is defined as at least a 15 point improvement in Neck Disability Index (NDI) Score at 120 months compared with baseline, maintenance or improvement in neurologic status at 120 months compared with baseline, no additional surgical procedure at the index level within 120 months, and the absence of a serious adverse event classified as implant-associated or implant/surgical procedure-associated within 120 months. A subject must meet each criterion to be considered an overall study success. NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.
10 years
Secondary Outcomes (12)
Percentage of subjects meeting the minimal clinically important difference (MCID) for NDI at each annual timepoint
10 years
Percentage of subjects meeting MCID for neck and arm pain questionnaire for each of the following pain locations: neck pain, arm pain, left arm pain, right arm pain.
10 years
Motor status at each annual timepoint compared to baseline
10 years
Sensory status at each annual timepoint compared to baseline
10 years
SF-36® Health Survey at each annual timepoint compared to baseline
10 years
- +7 more secondary outcomes
Study Arms (1)
Simplify Disc
Extended follow-up of subjects treated with the Simplify Disc during IDE study NCT03123549 and followed in the post-approval study NCT04980378.
Interventions
Simplify Disc is a weight-bearing cervical artificial disc implant consisting of PEEK (polyetheretherketone) endplates and one semi-constrained, fully articulating, mobile Zirconia Toughened Alumina ceramic (ZTA) core.
Eligibility Criteria
The study population includes subjects treated with the NuVasive Two Level Simplify Disc in IDE study (NCT03123549) and followed in the PAS (NCT04980378).
You may qualify if:
- Subject was enrolled in the Simplify Disc IDE (NCT03123549) and/or PAS (NCT04980378) at a participating study site
- Patient understands the conditions of enrollment and is willing sign an informed consent form to participate in the study
You may not qualify if:
- Subject had an SSI at the index level during the IDE study (NCT03123549) or the PAS (NCT04980378)
- Subject was withdrawn or withdrew consent to participate in the IDE study (NCT03123549) or PAS (NCT04980378)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NuVasivelead
Study Sites (2)
Carolina Neurosurgery and Spine Associates
Charlotte, North Carolina, 28204, United States
Texas Back Institute
Plano, Texas, 75093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kyle Malone
NuVasive
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2023
First Posted
January 19, 2023
Study Start
January 18, 2023
Primary Completion (Estimated)
February 10, 2029
Study Completion (Estimated)
May 10, 2029
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share